Clinical trial
Effects of Exenatide (Byetta®) on Biochemical and Histological Parameters of Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT01208649 is registered in ClinicalTrials.gov with Ruhr University of Bochum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Exenatide (Byetta®) on Biochemical and Histological Parameters of Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
- Lead sponsor
- Ruhr University of Bochum
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- September 30, 2010
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nonalcoholic fatty liver disease